More than 95% of the 1,741 participants in RIVM’s LongCOVID study, who reported long-term symptoms after COVID-19, had mild symptoms during the acute phase of the infection.

In 2020, the year of the coronavirus SARS-CoV-2 pandemic, resistant bacteria were not found more often in patients in the Netherlands than before the outbreak.

In the past week from 30 June to 6 July 2021, the number of reported positive COVID-19 tests doubled (+103%) compared to the previous week. This increase was observed in all security regions.

In 2019, the Dutch reporting centre for adverse effects of medical implants (MEBI) received 397 reports of suspected adverse effects. The reports concerned 462 implants.

It is estimated that about one-third of nursing homes in the Netherlands have at least one patient with COVID-19.

The actual number of deaths from the novel coronavirus in the Netherlands is higher than the reported numbers published by RIVM.

There are significant regional differences in the coronavirus epidemic in the Netherlands.